Nuclear Medicine: Page 21

Experts focus on expanding global radiation medicine capabilities

By Will Morton

Improving radiation medicine capabilities in poorer countries is key to bridging the massive global gap in cancer care, according to experts gathered this week during the International Atomic Energy Agency's 2022 Scientific Forum in Vienna.

September 27, 2022

Hermes Medical donates AI software to Regis College

By AuntMinnie.com staff writers

Sweden's Hermes Medical Solutions has donated molecular imaging artificial intelligence (AI) software to Regis College in Weston, MA, to help provide students a hands-on experience with the latest medical imaging technology in the field.

September 22, 2022

Isotopia inks deal to supply Lu-177 to Clovis Oncology

By AuntMinnie.com staff writers

Isotopia Molecular Imaging signed a two-year supply deal to provide Clovis Oncology with lutetium-177 (Lu-177).

September 20, 2022

Shine inks Lu-177 supply deal with Radiopharm Theranostics

By AuntMinnie.com staff writers

Shine Technologies has signed an agreement to supply Radiopharm Theranostics with noncarrier-added lutetium-177 (Lu-177).

September 19, 2022

NorthStar buys two additional accelerators from IBA

By AuntMinnie.com staff writers

NorthStar Medical Radioisotope has inked a deal to buy two more Rhodotron TT300 HE electron-beam accelerators and associated beamlines from Ion Beam Applications (IBA).

September 19, 2022

Does Tc-99m SPECT damage DNA?

By Will Morton

A common laboratory test called a "comet assay" shows that radiation from technetium-99m (Tc-99m) SPECT myocardial perfusion imaging poses little risk of damaging a patient's DNA, according to a Brazilian group.

September 19, 2022

BWXT Medical seeks FDA approval for Tc-99m generator

By AuntMinnie.com staff writers

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration (FDA) seeking approval of its technetium-99m (Tc-99m) generators for diagnostic imaging.

September 13, 2022

Radiopharm, MD Anderson launch new theranostics company

By AuntMinnie.com staff writers

Radiopharm Theranostics and the University of Texas MD Anderson Cancer Center (MD Anderson) have launched a new company that will develop new therapeutic radiopharmaceuticals for cancer treatment.

September 13, 2022

ARA named radiopharmaceutical 'center of excellence'

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has certified ARA Diagnostic Imaging's ARA Theranostics Center as a radiopharmaceutical therapy center of excellence.

September 13, 2022

RayzeBio makes development progress, nets $160M

By AuntMinnie.com staff writers

Radiopharmaceutical startup RayzeBio has made progress in the development of its RYZ101 targeted radiopharmaceutical candidate and secured $160 million in new financing.

September 13, 2022

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnie.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 12, 2022

Is scientific fraud rife in nuclear medicine journals?

By Will Morton

Scientific fraud may be a problem in nuclear medicine research journals, says a group in the Netherlands that conducted a recent global survey on the issue. Results were published September 8 in the Journal of Nuclear Medicine.

September 11, 2022

Previous Page

Page 21 of 442

Next Page